The infusion pumps market is experiencing significant growth due to the increasing demand for advanced healthcare solutions, particularly in the management of chronic diseases and critical care.

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

The Global Insulin Pump Market achieved a valuation of $5.90 Billion in 2024 and is anticipated to exceed $14.49 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 8.55% during the ...

Beck and colleagues from the JAEB Center for Health Research, Tampa, Florida, USA, highlight the rapid onset of action of inhaled Technosphere Insulin (TI, Afrezza) compare ...

Revolutionizing diabetes care with AI-driven, personalized treatment solutions. Explore key trends, market growth, and leading players shaping the future from 2025 to 2035 ...

For millions of people living with diabetes, managing blood sugar levels has always been a meticulous and demanding task. The ...

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

In a terrifying new report from Zurich-based cybersecurity Scip AG, experts revealed how they were easily able to hijack ...

It is taken during meals and leaves the system within two hours ... their latest study "Inhale 3" and say they show inhaled insulin to be as effective as traditional insulin shots or insulin pumps.

The findings demonstrated that AID systems were associated with superior glycaemic control compared to standard insulin ... and the fact that it primarily involved adults using insulin pumps or ...

Insulin pumps, for example ... and CEO John Sheridan said it’s “a natural evolution” to bring AID systems beyond type 1 and into the type 2 population. His company’s Control-IQ+ AID algorithm won the ...